All lobbying filings
Innovative Federal Strategies, LLC
Innovative Federal Strategies, LLC filed a Q4 report for Cerus Corporation on January 20, 2026, reporting $40,000 in lobbying income.
Lobbying for Cerus Corporation
Filing · LD-2 quarterly report
Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$40,000
What the client paid this registrant for the period.
Client based in
California
Government bodies contacted
4
Lobbying activity
3
Contacted officials regarding the Red Blood Cell Clinical Trial Program and blood safety issues.
H.R.4016/S.2572 Department of Defense Appropriations Bill, 2026, Title VI, all provisions related to blood safety. H.R.5304/S.2587 Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, 2026 - Title II, all provisions related to blood safety.
H.R.3838/S.2296 National Defense Authorization Act, 2026, Title XIV, all provisions related to blood safety.